Zimmer G, Mainka L, Ohlenschläger G
Arzneimittelforschung. 1980;30(4):632-5.
Having used 2-mercaptopropionylglycine in successful treatment of chronic hepatitis the mode of action of the reagent was further studied in rat liver mitochondrial membrane. Gradient polyacrylamide gel electrophoresis was employed for this purpose. It was found that after incubation of the mitochondria with ADP and 2-mercaptopropionylglycine and isolation of mitochondrial membranes the amount of low-molecular weight polypeptides was significantly increased. These polypeptides belong to the molecular weight ranges of the epsilon-subunits of the mitochondrial ATPase and of the oligomycin binding site. A working hypothesis is formed that the drug may improve anchoring the ATPase molecule at the membrane site. Such mechanism may elucidate previous biochemical findings, and, in particular, underlines the structure-preserving effect of 2-mercaptopropionylglycine in mitochondria.
在成功使用2-巯基丙酰甘氨酸治疗慢性肝炎后,对该试剂在大鼠肝线粒体膜中的作用方式进行了进一步研究。为此采用了梯度聚丙烯酰胺凝胶电泳。结果发现,线粒体与ADP和2-巯基丙酰甘氨酸孵育并分离线粒体膜后,低分子量多肽的数量显著增加。这些多肽属于线粒体ATP酶的ε亚基和寡霉素结合位点的分子量范围。由此形成了一个工作假设,即该药物可能改善ATP酶分子在膜位点的锚定。这种机制可以解释先前的生化发现,特别是强调了2-巯基丙酰甘氨酸在线粒体中的结构保护作用。